Viswanathan Anuradha, Sylvester Francisco A
University of Connecticut School of Medicine, Farmington, CT, USA.
Rev Endocr Metab Disord. 2008 Jun;9(2):107-22. doi: 10.1007/s11154-007-9070-0. Epub 2007 Dec 29.
In children, chronic inflammatory diseases present a significant challenge to long-term skeletal health. These conditions are often associated with poor appetite and suboptimal overall nutrition, altered nutrient utilization, delayed puberty, inactivity, and reduced muscle mass, all of which can alter bone metabolism. In addition, bone cell activity is susceptible to the effects of the immune response that characterizes these diseases. Moreover, drugs used to treat these maladies, notably glucocorticoids, may have negative effects on bone formation and on linear growth in developing children. As a result, predicted peak bone mass may not be achieved, and fracture risk may be increased in the short term or in the future. Studies using primarily dual energy X-ray absorptiometry have documented that deficits in bone mass are common in these diseases. However, there are wide variations in the prevalence of low bone mass, largely due to differences in the characteristics of each study population. Recent studies provide insight into the pathogenesis of decreased bone mass in these conditions. In this paper we will provide an overview of the effects of chronic inflammatory conditions on bone mass in children. We will also present relevant data from adult patients, when pediatric data are scant or not available.
在儿童中,慢性炎症性疾病对长期骨骼健康构成重大挑战。这些病症通常与食欲不振和整体营养欠佳、营养利用不良、青春期延迟、活动不足以及肌肉量减少有关,所有这些都会改变骨代谢。此外,骨细胞活性易受这些疾病所特有的免疫反应的影响。而且,用于治疗这些疾病的药物,尤其是糖皮质激素,可能会对发育中的儿童的骨形成和线性生长产生负面影响。因此,可能无法达到预测的峰值骨量,并且在短期内或未来骨折风险可能会增加。主要使用双能X线吸收法的研究表明,这些疾病中骨量不足很常见。然而,低骨量的患病率存在很大差异,这主要是由于每个研究人群的特征不同。最近的研究为这些情况下骨量减少的发病机制提供了见解。在本文中,我们将概述慢性炎症性疾病对儿童骨量的影响。当儿科数据不足或无法获得时,我们还将展示来自成年患者的相关数据。